CRBN ligands and uses thereof
US11512080B2 · kind B2 · utility
7Cited by
53References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 14, 2019 |
| Grant date | Nov 29, 2022 |
| Priority date | — |
| Expiry date | Jan 17, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of CRBN, and the treatment of CRBN-mediated disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.